Previous 10 | Next 10 |
Investing News Network news releases related Investing News Network news releases and Investing News Network press releases from 10/02/19 07:50:43 on US...
Swiss investment company Pala Investments has increased its acquisition offer for Cobalt 27 Capital (TSXV: KBLT ,OTCQX:CBLLF) by C$30 million. Pala Investments, which already owns 19 percent of the Toronto-based company, is now offering C$4 per share, up from C$3.57. Shareholders will also r...
Swiss investment company Pala Investments has increased its acquisition offer for Cobalt 27 Capital (TSXV: KBLT ,OTCQX:CBLLF) by C$30 million. Pala Investments, which already owns 19 percent of the Toronto-based company, is now offering C$4 per share, up from C$3.57. Shareholders will also r...
Swiss investment company Pala Investments has increased its acquisition offer for Cobalt 27 Capital (TSXV: KBLT ,OTCQX:CBLLF) by C$30 million. Pala Investments, which already owns 19 percent of the Toronto-based company, is now offering C$4 per share, up from C$3.57. Shareholders will also r...
Swiss investment company Pala Investments has increased its acquisition offer for Cobalt 27 Capital (TSXV: KBLT ,OTCQX:CBLLF) by C$30 million. Pala Investments, which already owns 19 percent of the Toronto-based company, is now offering C$4 per share, up from C$3.57. Shareholders will also r...
Canopy Growth (NYSE: CGC ,TSX:WEED) is positioning itself to take on the cannabidiol (CBD)-infused sport nutrition industry. The Canadian cannabis giant confirmed on Wednesday (October 2) that it has completed a majority stake purchase of BioSteel Sports Nutrition, a producer of sport and ...
Play Video Charlie Glavin, CFO of Boardwalktech (TSXV: BWLK ), spoke with the Investing News Network about how enterprises apply blockchain technology to improve both operational efficiencies and return on...
Pharma giant GlaxoSmithKline (NYSE: GSK ) revealed on Wednesday (October 2) that it has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for its single inhaler triple therapy to treat asthma. The inhaler, called Trelegy Ellipta, was initia...
Pharma giant GlaxoSmithKline (NYSE: GSK ) revealed on Wednesday (October 2) that it has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for its single inhaler triple therapy to treat asthma. The inhaler, called Trelegy Ellipta, was initia...
Pharma giant GlaxoSmithKline (NYSE: GSK ) revealed on Wednesday (October 2) that it has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for its single inhaler triple therapy to treat asthma. The inhaler, called Trelegy Ellipta, was initia...
Pharma giant GlaxoSmithKline (NYSE: GSK ) revealed on Wednesday (October 2) that it has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for its single inhaler triple therapy to treat asthma. The inhaler, called Trelegy Ellipta, was initia...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
1.06%Change Percent:
ServiceMaster Global Holdings Inc. Company Name:
SERV Stock Symbol:
NYSE Market:
serverobotics.com/ Website: